Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,211 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomised phase II trial of capecitabine plus cisplatin versus S-1 plus cisplatin as a first-line treatment for advanced gastric cancer: Capecitabine plus cisplatin ascertainment versus S-1 plus cisplatin randomised PII trial (XParTS II).
Nishikawa K, Tsuburaya A, Yoshikawa T, Kobayashi M, Kawada J, Fukushima R, Matsui T, Tanabe K, Yamaguchi K, Yoshino S, Takahashi M, Hirabayashi N, Sato S, Nemoto H, Rino Y, Nakajima J, Aoyama T, Miyagi Y, Oriuchi N, Yamaguchi K, Miyashita Y, Morita S, Sakamoto J. Nishikawa K, et al. Among authors: sato s. Eur J Cancer. 2018 Sep;101:220-228. doi: 10.1016/j.ejca.2018.06.026. Epub 2018 Aug 7. Eur J Cancer. 2018. PMID: 30096702 Clinical Trial.
A randomized phase-II trial comparing sequential and concurrent paclitaxel with oral or parenteral fluorinated pyrimidines for advanced or metastatic gastric cancer.
Nishikawa K, Morita S, Matsui T, Kobayashi M, Takeuchi Y, Takahashi I, Sato S, Miyashita Y, Tsuburaya A, Sakamoto J, Kakeji Y, Baba H. Nishikawa K, et al. Among authors: sato s. Gastric Cancer. 2012 Oct;15(4):363-9. doi: 10.1007/s10120-011-0124-3. Epub 2012 Jan 26. Gastric Cancer. 2012. PMID: 22278377 Clinical Trial.
Randomized phase III trial of treatment duration for oral uracil and tegafur plus leucovorin as adjuvant chemotherapy for patients with stage IIB/III colon cancer: final results of JFMC33-0502.
Sadahiro S, Tsuchiya T, Sasaki K, Kondo K, Katsumata K, Nishimura G, Kakeji Y, Baba H, Sato S, Koda K, Yamaguchi Y, Morita T, Matsuoka J, Usuki H, Hamada C, Kodaira S. Sadahiro S, et al. Among authors: sato s. Ann Oncol. 2015 Nov;26(11):2274-80. doi: 10.1093/annonc/mdv358. Epub 2015 Sep 7. Ann Oncol. 2015. PMID: 26347106 Free PMC article. Clinical Trial.
Safety analysis of two different regimens of uracil-tegafur plus leucovorin as adjuvant chemotherapy for high-risk stage II and III colon cancer in a phase III trial comparing 6 with 18 months of treatment: JFMC33-0502 trial.
Tsuchiya T, Sadahiro S, Sasaki K, Kondo K, Katsumata K, Nishimura G, Kakeji Y, Baba H, Morita T, Koda K, Sato S, Matsuoka J, Yamaguchi Y, Usuki H, Hamada C, Kodaira S, Saji S. Tsuchiya T, et al. Among authors: sato s. Cancer Chemother Pharmacol. 2014 Jun;73(6):1253-61. doi: 10.1007/s00280-014-2461-5. Epub 2014 Apr 18. Cancer Chemother Pharmacol. 2014. PMID: 24744162 Free PMC article. Clinical Trial.
Retrospective Risk Analysis for Anastomotic Leakage Following Laparoscopic Rectal Cancer Surgery in a Single Institute.
Hiraki M, Tanaka T, Ikeda O, Sadashima E, Kimura N, Nakamura S, Nakamura H, Yamada K, Okuyama K, Yamaji K, Manabe T, Miyoshi A, Kitahara K, Sato S, Noshiro H. Hiraki M, et al. Among authors: sato s. J Gastrointest Cancer. 2020 Sep;51(3):908-913. doi: 10.1007/s12029-019-00315-9. J Gastrointest Cancer. 2020. PMID: 31713046 Clinical Trial.
12,211 results
You have reached the last available page of results. Please see the User Guide for more information.